The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Helsinn Healthcare; Kyowa Kirin; Mallinckrodt; Regeneron; Sanofi; Sanofi
Research Funding - Helsinn Therapeutics; Innate Pharma; Kyowa Kirin; Mallinckrodt; Merck; Soligenix
Predictors of immediate and delayed cutaneous hypersensitivity reactions to paclitaxel.
 
Megan Hannah Trager
Patents, Royalties, Other Intellectual Property - Publication Number US-2024-0008798-A1
 
Alyce Mei-Shiuan Kuo
No Relationships to Disclose
 
Stephen W. Dusza
No Relationships to Disclose
 
Vivian Park
No Relationships to Disclose
 
Larisa J. Geskin
No Relationships to Disclose
 
Autumn Guyer
No Relationships to Disclose
 
Nour Abuhadra
No Relationships to Disclose
 
Ayca Gucalp
Research Funding - BioAtla (Inst); Bristol-Myers Squibb (Inst); Innocrin Pharma (Inst); Merck (Inst); Novartis (Inst); OncoTherapy Science (Inst); Pfizer (Inst); Roche (Inst); Zenith Epigenetics (Inst)
 
Mario E. Lacouture
Stock and Other Ownership Interests - Oncoderm (I)
Honoraria - Apricity Health; AstraZeneca; Deciphera; Hoth Therapeutics; Incyte; Innovaderm; Janssen; Kinnate Biopharma; Kintara Therapeutics; Kintara Therapeutics; L'Oreal; La Roche-Posay; Loxo; Lutris; MJH Associates; Nanology; Novartis; Novocure; OnQuality Pharmaceuticals; RBC consultants; Relay Therapeutics; Repare Therapeutics; Roche/Genentech; Seagen; Seattle Genetics/Astellas; Trifecta; Tyra Biosciences
Consulting or Advisory Role - Apricity Health; AstraZeneca; Deciphera; Genentech; Incyte; Innovaderm; Janssen Research & Development; Kinnate Biopharma; Kintara Therapeutics; Kintara Therapeutics; La Roche-Posay; Loxo; Loxo; Lutris; Novartis; Novocure; OnQuality Pharmaceuticals; Relay Therapeutics; Repare Therapeutics; Repare Therapeutics; Roche; Roche; Seagen; Tyra Biosciences
Research Funding - AstraZeneca/MedImmune (Inst); Columbia University (Inst); Lutris (Inst); Lutris (Inst); National Jewish Health (Inst); Novartis (Inst); novocure (Inst); novocure (Inst); OnQuality Pharmaceuticals; OnQuality Pharmaceuticals (Inst); Paxman (Inst)
Other Relationship - Oncoderm (I)
(OPTIONAL) Uncompensated Relationships - Oncoderm